These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23528580)

  • 1. [The effect of mexidol in the combination with antidepressants on sleep disturbance in young patients with panic disorder].
    Kursakov ES; Remizevich RS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(2):33-8. PubMed ID: 23528580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fluvoxamine (fevarin) in the treatment of depression].
    Sheĭfer MS; Tsybina MI; Davydenko MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(12):64-7. PubMed ID: 11195542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sleep disturbances in panic disorders].
    Korabelnikova EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(4. Vyp. 2):99-106. PubMed ID: 30059058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open trial of fluvoxamine therapy for panic disorder complicated by depression.
    Spiegel DA; Saeed SA; Bruce TJ
    J Clin Psychiatry; 1996; 57 Suppl 8():37-40; discussion 40-1. PubMed ID: 8698679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of mexidol in psychiatric practice].
    Kosenko VG; Karagezian EA; Luneva LV; Smolenko LF
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(6):38-41. PubMed ID: 16841482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fluvoxamine on panic disorder.
    Hoehn-Saric R; McLeod DR; Hipsley PA
    J Clin Psychopharmacol; 1993 Oct; 13(5):321-6. PubMed ID: 8227490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of sleep in escitalopram-treated female patients with panic disorder.
    Todder D; Baune BT
    Hum Psychopharmacol; 2010 Mar; 25(2):167-73. PubMed ID: 20066671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose venlafaxine treatment in panic disorder.
    Papp LA; Sinha SS; Martinez JM; Coplan JD; Amchin J; Gorman JM
    Psychopharmacol Bull; 1998; 34(2):207-9. PubMed ID: 9641002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep in panic disorders.
    Lepola U; Koponen H; Leinonen E
    J Psychosom Res; 1994; 38 Suppl 1():105-11. PubMed ID: 7799242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
    Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D
    Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in the Study of Sleep in the Anxiety Disorders, Obsessive-Compulsive Disorder, and Posttraumatic Stress Disorder.
    Boland EM; Ross RJ
    Psychiatr Clin North Am; 2015 Dec; 38(4):761-76. PubMed ID: 26600107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nocturnal panic attacks.
    Lopes FL; Nardi AE; Nascimento I; Valenca AM; Zin WA
    Arq Neuropsiquiatr; 2002 Sep; 60(3-B):717-20. PubMed ID: 12364936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of sleep research to the development of new antidepressants.
    Le Bon O
    Dialogues Clin Neurosci; 2005; 7(4):305-13. PubMed ID: 16416706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schneiderian first-rank symptoms associated with fluvoxamine treatment: a case report.
    Ueda N; Terao T; Ohmori O; Nakamura J
    Hum Psychopharmacol; 2003 Aug; 18(6):477-8. PubMed ID: 12923827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panic disorder, autonomic nervous system and dissociation - changes during therapy.
    Prasko J; Latalova K; Diveky T; Grambal A; Kamaradova D; Velartova H; Salinger J; Opavsky J; Silhan P
    Neuro Endocrinol Lett; 2011; 32(5):641-51. PubMed ID: 22167145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden arousals from slow wave sleep and panic disorder: successful treatment with anticonvulsants--a case report.
    Dantendorfer K; Frey R; Maierhofer D; Saletu B
    Sleep; 1996 Nov; 19(9):744-6. PubMed ID: 9122563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sleep disturbances and depression: a challenge for antidepressants].
    Lem RV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):75-8. PubMed ID: 19256091
    [No Abstract]   [Full Text] [Related]  

  • 18. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dosage of levomepromazine did not increase plasma concentrations of fluvoxamine.
    Yoshimura R; Ueda N; Nakamura J
    Int Clin Psychopharmacol; 2000 Jul; 15(4):233-5. PubMed ID: 10954064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary study of fluvoxamine maleate on depressive state and serum melatonin levels in patients after cerebral infarction.
    Sunami E; Usuda K; Nishiyama Y; Otori T; Katsura K; Katayama Y
    Intern Med; 2012; 51(10):1187-93. PubMed ID: 22687788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.